Insuring rapid and robust safety assessment

J Invest Dermatol. 2004 Mar;122(3):857-8. doi: 10.1111/j.0022-202X.2004.22345.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell / chemically induced*
  • Drug Industry
  • Humans
  • PUVA Therapy / adverse effects*
  • Risk Assessment
  • Skin Neoplasms / chemically induced*
  • United States
  • United States Food and Drug Administration